Remove Bioinformatics Remove Drugs Remove Pharma Companies
article thumbnail

Big pharma companies partner to form AI-based start-up

pharmaphorum

Built under a government tender, AION Labs comprises four large international pharma companies – AstraZeneca , Merck, Pfizer , and Teva – and another core partner, the Israel Biotech Fund. The post Big pharma companies partner to form AI-based start-up appeared first on. The partnership.

article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . The post Digitalising drug discovery appeared first on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Country focus: Hungary carves out a niche in digital pharma

pharmaphorum

AI simulated cell company Turbine is just one of many digital drug discovery firms on the rise in Hungary. We speak to the company’s CEO and co-founder, Szabolcs Nagy, to find out why moving beyond traditional biotech drug development is a good fit for the country’s ecosystem. They go into bioinformatics”.

article thumbnail

How digital is transforming the commercial leader’s role in biopharma

pharmaphorum

A range of pharma leaders is critical to realising these new digital opportunities, including IT, regulatory, data, digital, and R&D heads. However, pharma’s commercial leaders are uniquely positioned to drive the strategic digital shift in patient care journeys. Then, they can scale the lessons across a broader drug portfolio.

Marketing 133
article thumbnail

Eisai-backed trial will assess Altoida’s digital test for early Alzheimer’s

pharmaphorum

The trial – which will be supported by pharma company Eisai and Ionian University in the US – will see if the test can identify people who have mild cognitive impairment (MCI) due to Alzheimer’s disease.

Trials 78
article thumbnail

Sandoz, Ares extend digital alliance on antimicrobial resistance

pharmaphorum

During the initial stage of the collaboration, Ares developed a an AI-powered anti-infectives platform using microbiological lab techniques and bioinformatics that can be used to identify effective antimicrobial compounds or combinations against specific pathogens, which Sandoz can use to inform its “portfolio and commercial decisions.”

article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

data processing systems that support bioinformatics modelling) and digital record systems (e.g. However, if considered early in the drug development plan, compliance is by no means insurmountable and would be offset by the benefits of digital healthcare tools for patient engagement. video consultations), health data analytics (e.g.